Step-by-step clinical titration schedules, receptor adaptation, and administration instructions.
Primary Pharmacological Mechanism: Upregulation of vascular endothelial growth factor (VEGF), early growth response protein 1 (EGR-1), and FAK-paxillin pathway acceleration, promoting rapid capillary angiogenesis and collagen cross-linking.
Clinical Protocol Summary: Systemic/Subcutaneous: 250mcg to 500mcg twice daily for 4-6 weeks. Oral arginate salt: 500mcg once daily on empty stomach for inflammatory bowel issues.
Authentic batches verified by ISO/WHO-GMP laboratories are available directly through licensed telehealth physician consultation.